E Fund Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $743K | Buy |
65,954
+19,626
| +42% | +$221K | 0.04% | 194 |
|
|
2025
Q1 | $467K | Sell |
46,328
-4,319
| -9% | -$43.6K | 0.02% | 234 |
|
|
2024
Q4 | $599K | Buy |
50,647
+8,535
| +20% | +$101K | 0.03% | 200 |
|
|
2024
Q3 | $486K | Sell |
42,112
-8,269
| -16% | -$95.4K | 0.03% | 199 |
|
|
2024
Q2 | $533K | Buy |
50,381
+9,805
| +24% | +$104K | 0.03% | 172 |
|
|
2024
Q1 | $428K | Sell |
40,576
-8,284
| -17% | -$87.3K | 0.03% | 191 |
|
|
2023
Q4 | $549K | Buy |
48,860
+12,569
| +35% | +$141K | 0.03% | 140 |
|
|
2023
Q3 | $424K | Sell |
36,291
-2,434
| -6% | -$28.4K | 0.03% | 157 |
|
|
2023
Q2 | $390K | Sell |
38,725
-3,621
| -9% | -$36.5K | 0.03% | 179 |
|
|
2023
Q1 | $313K | Buy |
42,346
+29,236
| +223% | +$216K | 0.02% | 217 |
|
|
2022
Q4 | $105K | Buy |
+13,110
| New | +$105K | 0.01% | 329 |
|